title: Norwegian physicians' knowledge of the prices of pharmaceuticals: a survey.
abstract: The objectives of this study are to measure physicians' knowledge of the prices of pharmaceuticals, and investigate whether there are differences in knowledge of prices between groups of physicians. This article reports on a survey study of physicians' knowledge of the prices of pharmaceuticals conducted on a representative sample of Norwegian physicians in the autumn of 2010. The importance of physicians' knowledge of costs derives from their influence on total spending and allocation of limited health-care resources. Physicians are important drivers in the effort to contain costs in health care, but only if they have the knowledge needed to choose the most cost-effective treatment options. A survey was sent to 1543 Norwegian physicians, asking them for price estimates and their opinions on the importance of considering the cost of treatment to society as a decision factor when treating their patients. This article deals with a subsection in which the physicians were asked to estimate the price of five pharmaceuticals: simvastatin, alendronate (Fosamax), infliximab (Remicade), natalizumab (Tysabri) and escitalopram (Cipralex). The response rate was 65%. For all the five pharmaceuticals, more than 50% and as many as 83% gave responses that differed more than 50% from the actual drug price. The price of more expensive pharmaceuticals was underestimated, while the opposite was the case for less expensive medicines. The data show that physicians in general have poor knowledge of the prices of the pharmaceuticals they offer their patients. However, the physicians who frequently deal with a drug have better knowledge of its price than those who do not handle a medication as often. The data also suggest that those physicians who agree that cost of care to society is an important decision factor have better knowledge of drug prices.
authors.affiliation: University of Oslo, Department of Health Management and Health Economics, Oslo, Norway.
authors.forename: Ida Iren
authors.initials: II
authors.lastname: Eriksen
authors.forename: Hans Olav
authors.initials: HO
authors.lastname: Melberg
authors.forename: Berit
authors.initials: B
authors.lastname: Bringedal
mesh_terms: D000328:Adult; D000367:Age Factors; D003132:Commerce; D003362:Cost-Benefit Analysis; D003625:Data Collection; D005260:Female; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D009664:Norway; D004364:Pharmaceutical Preparations / Q000191:economics*; D010820:Physicians / Q000706:statistics & numerical data*; D012737:Sex Factors
chemical_list: D004364:Pharmaceutical Preparations
references.citation: Arch Intern Med. 2000 Oct 9;160(18):2799-803
references.pmid: 11025790
references.citation: Br J Gen Pract. 1992 Jan;42(354):6-9
references.pmid: 1586545
references.citation: Scand J Public Health. 2006;34(6):654-9
references.pmid: 17132599
references.citation: Int J Technol Assess Health Care. 2008 Spring;24(2):158-65
references.pmid: 18400118
references.citation: Can Fam Physician. 2004 Feb;50:263-70
references.pmid: 15000338
references.citation: West J Med. 2000 Dec;173(6):390-4
references.pmid: 11112752
references.citation: J Med Ethics. 2001 Aug;27(4):268-74
references.pmid: 11479359
references.citation: J Health Econ. 2010 Sep;29(5):751-64
references.pmid: 20708282
references.citation: Med Educ. 1985 Mar;19(2):113-7
references.pmid: 3982310
references.citation: JAMA Intern Med. 2013 May 27;173(10):903-8
references.pmid: 23588900
references.citation: J Health Econ. 2012 Jan;31(1):296-305
references.pmid: 22192424
references.citation: Int J Technol Assess Health Care. 2008 Winter;24(1):45-51
references.pmid: 18218168
references.citation: Tidsskr Nor Laegeforen. 2010 Mar 25;130(6):598-600
references.pmid: 20349003
references.citation: Arch Fam Med. 2000 Nov-Dec;9(10):1002-7
references.pmid: 11115199
references.citation: J Gen Intern Med. 2003 Jan;18(1):31-7
references.pmid: 12534761
references.citation: J Pain Symptom Manage. 1995 Aug;10(6):432-5
references.pmid: 7561225
references.citation: Acta Anaesthesiol Scand. 1999 Feb;43(2):202-5
references.pmid: 10027029
references.citation: J Grad Med Educ. 2011 Jun;3(2):182-7
references.pmid: 22655140
references.citation: J Med Ethics. 1995 Jun;21(3):158-61
references.pmid: 7674280
references.citation: Ann Intern Med. 2012 Jan 3;156(1 Pt 2):73-104
references.pmid: 22213573
references.citation: BMJ. 1990 May 19;300(6735):1316-8
references.pmid: 2369666
references.citation: PLoS Med. 2007 Sep;4(9):e283
references.pmid: 17896856
references.citation: Intensive Care Med. 1998 Nov;24(11):1194-8
references.pmid: 9876983
references.citation: J Intern Med. 1993 Aug;234(2):155-63
references.pmid: 8340738